France-based veterinary care and preclinical research company
Hawkcell has raised €5.0M across 1 funding round from 2 investors, most recently a Series A round in Mar 2024. Based in Lyon, France; active in Consumer. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-14 | Series A | €5.0M |
| French investment bank,MIG |
| View deal → |